TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathway
Authors:
Open Access
- 6 September 2021
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 14 (12) , 101214
Abstract
No abstract availableKeywords
Funding Information
- Nanjing Medical University
- Wuxi health commission (Z201809)
This publication has 26 references indexed in Scilit:
- Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cellsProceedings of the National Academy of Sciences, 2012
- PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytesProceedings of the National Academy of Sciences, 2011
- Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1α in human colon cancer cellsToxicology and Applied Pharmacology, 2009
- Essential Role for TRPC5 in Amygdala Function and Fear-Related BehaviorCell, 2009
- Temozolomide with Radiation Therapy in High Grade Brain Gliomas: Pharmaceuticals Considerations and Efficacy;A Review ArticleMolecules, 2009
- Adenovirus-Based Strategies Overcome Temozolomide Resistance by Silencing the O6-Methylguanine-DNA Methyltransferase PromoterCancer Research, 2007
- Upregulation of TRPC1 in the development of cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 2007
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- P-Glycoprotein, a gatekeeper in the blood–brain barrierAdvanced Drug Delivery Reviews, 1999